Condition: Myopia · Sponsor: CooperVision International Limited (CVIL)
The main objective of this post market clinical study is to evaluate the effectiveness and safety of the Paragon CRT®100 Contact Lens.
This description comes directly from the study's public registry record.
Jose Vega, OD, MSc · 9256402964 · jvega2@coopervision.com
Always discuss trial participation with your own doctor first.
| Changsha Aier Eye Hospital | Shanghai, China | Recruiting |
| Eye & ENT Hospital of Fudan University | Shanghai, China | Recruiting |
| Tianjin Eye Hospital | Tianjin, China | Recruiting |
| The Affiliated Eye Hospital of Wenzhou Medical University | Wenzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04187599